Cipralex shows fewer side-effects than Efexor
October 25, 2004Lundbeck says two new studies prove that patients taking its antidepressant Cipralex (escitalopram) gain relief faster and suffer fewer side-effects …
Equality champion to tackle NHS diversity agenda
October 21, 2004The NHS has engaged its first equality and human rights director to head up its diversity agenda. Surinder Sharma has …
Abbott third quarter profits grow as Humira sales soar
October 21, 2004Abbott Laboratories' third quarter profits grew by 8.7% to $853 million, driven by global sales increases of 10.2%, which were …
Buoyant Roche to enter cholesterol market
October 21, 2004Roche has announced an alliance with a Japanese company to develop and market JTT-705 a promising new treatment for cholesterol.The …
Immunisation factfile launched to promote 5-in-1 jab
October 13, 2004France, MMR, public health, vaccines
Aventis Pasteur MSD has collaborated with public health bodies in producing a Factfile in support of the company’s new 5-in-1 …
RSA launches consultancy division
October 13, 2004Recruitment services company RSA has launched a new division to offer specialised consulting services to the pharma and biotech industries. …
Climbing the knowledge pyramid
October 11, 2004Product and marketing management are key roles in a brand-led pharma business. The majority of post holders come from within …
GP commissioning returns but PCTs will hold purse strings
October 7, 2004General practices will be able to commission care and services directly from suppliers from April next year – a move …
Chiron suspension threatens US flu jab shortage
October 7, 2004The US is facing a 50% shortfall in the supply of flu vaccines after regulators suspended production and distribution from …
Pfizer distances Celebrex from COX-II safety concerns
October 7, 2004Pfizer has restated the safety of its blockbuster arthritis pain drug Celebrex following the withdrawal of Merck's rival drug Vioxx …
Latest content
FibroFind appoints Lee Borthwick as CEO
